Hepatitis C Treatment Study in Myanmar

Condition:   Hepatitis C Intervention:   Drug: Sofosbuvir 400 mg Sponsor:   Myanmar Oxford Clinical Research Unit Not yet recruiting - verified May 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials